Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novo Nordisk, Ozempic and Medicare
Novo says Ozempic 'very likely' to be on 2027 Medicare negotiation list, Bloomberg News reports
Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will "very likely" be on the U.S. government's 2027 list of price negotiations, Bloomberg News reported on Tuesday citing a company executive.
Cassidy seeks to exempt small biotechs from Medicare drug price negotiation
WASHINGTON — Sen. Bill Cassidy (La.), a key Republican senator with seats on the chamber’s health and finance committees, introduced a bill to let some small drugmakers avoid Medicare price negotiations.
What Medicare Negotiation Tells Us About Drug Pricing In The U.S.
Results from Medicare’s first year of negotiation with other price benchmarks shed light on the competitive dynamics and payer negotiations that shape what the U.S. pays for prescription drugs.
1d
An appeals court has revived a challenge to President Biden’s Medicare drug price reduction program
A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription ...
Opinion
3h
Opinion
COMMENTARY: Stop the Biden-Harris raid on Medicare
The Inflation Reduction Act raids an estimated $260 billion in reduced Medicare drug spending to pay for unrelated spending.
19h
on MSN
Four things you need to know about Medicare drug costs and coverage in 2025
With Medicare prescription-drug benefits on the brink of a shake-up, enrollees who hope to minimize their costs at the ...
pharmaphorum
2d
ICER mulls GSK COPD drugs ahead of next Medicare negotiation
The Centers for Medicare & Medicaid Services (CMS) has said it will announce the next 15 drugs in scope for the second round ...
1d
on MSN
Challenge to US drug price negotiation program revived by appeals court
A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback